IQVIA Acquires Remaining Interest in Q2 Solutions from Quest Diagnostics; Raises Full Year 2021 Adjusted Diluted EPS GuidanceBusiness Wire • 04/01/21
Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics for Cardiovascular Mortality Prediction TestPRNewsWire • 03/15/21
Quest Diagnostics Updates Strategic Growth Drivers and Provides Long-Term Outlook at 2021 Virtual Investor DayPRNewsWire • 03/11/21
Quest Diagnostics and Mercy Broaden Access to Innovative, Convenient Lab Services in the MidwestPRNewsWire • 03/08/21
Quest Diagnostics Introduces New COVID-19 Semi-quantitative Serology Test ServicePRNewsWire • 02/24/21
GRAIL and Quest Diagnostics Announce Collaboration to Support Galleri, First-of-Kind Multi-Cancer Early Detection Blood TestBusiness Wire • 02/23/21
Quest Diagnostics Incorporated (DGX) CEO Steve Rusckowski on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/04/21
Quest Diagnostics (DGX) Surpasses Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/04/21
Quest Diagnostics increases quarterly dividend, boosts share buyback by $1 billionMarket Watch • 02/04/21